Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 17,375 shares at $128.09 ($2.2M) on 2017-02-07, disclosed to the SEC on 2017-02-08.
Seasonal sale ($2.2M) by Director — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.69 | 7,640 | $960K | 43.9% |
| 2 | $125.69 | 7,640 | $960K | 43.9% |
| 3 | $126.09 | 75 | $9K | 0.4% |
| 4 | $128.09 | 1,010 | $129K | 5.9% |
| 5 | $128.09 | 1,010 | $129K | 5.9% |
| Total | $125.97 avg | 17,375 |
| $2.2M |
| 100% |
| Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |
| ALXN | SELL | 2016-11-07 | $5.2M | — | Filing → |